How Big Pharma Uses Charity Programs To Cover Drug Price Hikes

Looking for another reason to dislike drug companies? Good news: Some companies systematically use charitable giving as a way to raise their drug prices with minimal public awareness.

Bloomberg’s Benjamin Elgin and Robert Langreth reported on a number of cases in which drug companies seem to be using charities as a means to milk U.S. taxpayers for all they’re worth.

Drug companies donate to charities that help patients who are unable to afford the insurance co-payments on expensive drugs.

The drug companies donate to the co-pay charities so that Americans can afford the out-of-pocket costs of staying on extremely expensive drugs, while the taxpayer-funded Medicare program shoulders the largest part of the total cost.

The seven largest co-pay charities in the country received $1.1 billion in total contributions from drug companies in 2014.

While the law strictly forbids drug companies from giving direct help to Medicare patients, there is no law forbidding them from donating to co-pay charities, which themselves directly help Medicare patients.

Former Turing Pharmaceuticals CEO Martin Shkreli is reportedly one of many to take advantage of the system. When Turing purchased the drug Daraprim last year, Shkreli immediately raised the drug’s price by more than 5,000 percent. Turing then turned around and donated more than a million dollars to co-pay charity Patient Services Inc to ensure that all of its patients would continue to be able to afford their out-of-pocket costs and Turing could gouge Medicare for the majority of the price hike.

Notable Names

The authors specifically mentioned…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!